A new scientific research paper questions the legitimacy of “Post Treatment Lyme Syndrome” also known as PTLS
News
The latest news regarding Morgellons Disease is curated here on the Morgellons Survey website. Like, share, and subscribe for future updates.
Chronic Lyme Disease: a Case Definition at Last
SAN FRANCISCO, CA (PRWEB) MAY 09, 2017
For years, Lyme disease patients with chronic symptoms have been denied care because there was no formal recognition of their disease. Now for the first time researchers from the International Lyme and Associated Diseases Society (ILADS) have published a groundbreaking case definition of chronic Lyme disease in the prestigious medical journal Chronic Diseases International.
EPA Enterprises launches Cutter™ Lyme Disease Tick Test that provides quick, inexpensive and 99.9% accurate DNA test result.
BRODHEADSVILLE, Pa., June 7, 2017 /PRNewswire/ — You find a tick on yourself, your child, or your pet. You worry, does it carry Lyme disease? Now, finding an answer can be as close as your medicine cabinet, first aid kit or backpack. With the new Cutter™ Lyme Disease Tick Test you’ll get a fast, 99.9% accurate DNA test result that tells you if a tick is a carrier of Lyme disease. It tests the tick, not the person or pet.
New Book Reveals Truth Behind Morgellons Disease
The Charles E. Holman Morgellons Disease Foundation announces best selling book authored by medical advisor, Ginger Savely, DNP
AUSTIN, TX (PRWEB) JANUARY 09, 2017
Ginger Savely, world-renowned expert on Morgellons disease, Lyme disease and other tickborne infections, has released her long-awaited and ground-breaking first book, Morgellons: The Legitimization of a Disease.
Bacterial Biofilm Infections: Personalizing Patient Treatment
Bacterial Biofilm Infections. Content curated from: http://www.prweb.com/releases/2017/05/prweb14360614.htm
SAN DIEGO, CA (PRWEB) MAY 23, 2017
Bacterial biofilms, surface adherent communities of bacteria that are encased in a secreted extracellular matrix of polymeric molecules, can cause diverse pathologies ranging from food poisoning and catheter infections to gum disease and the rejection of medical implants. Though the economic impact of biofilms is in the tens of billions of dollars per year, there is currently a paucity of means for preventing their formation or treating them once they are established. Compared to the free-floating “planktonic” lifestyle, within biofilms bacteria adopt differential gene expression profiles, have heightened resistance to antibiotics (up to 1,000-fold), and are less detectable/ accessible to the immune system. The current approach for treating biofilm infections is far from optimal: antibiotics are administered in a trial-and-error manner.